United States Tendon Repair Market By Product (Rotator Cuff Repair, Achilles Tendinosis Repair, Cruciate Ligament Repair, Biceps Tenodesis, and Others), By Ventilation Mode/Interphase (Implants, Suture Anchor Devices, Grafts, Matrix/Scaffolds (Tendon Repair, Tendon Protection Matrix/Scaffolds), Screws, and Others), By Region, Competition, Forecast and Opportunities, 2021-2031F

Forecast Period	2027-2031
Market Size (2025)	USD 189.56 Billion
CAGR (2026-2031)	4.05%
Fastest Growing Segment	Rotator Cuff Repair
Largest Market	Midwest
Market Size (2031)	USD 240.55 Billion

Market Overview

The United States Tendon Repair Market will grow from USD 189.56 Billion in 2025 to USD 240.55 Billion by 2031 at a 4.05% CAGR. The United States Tendon Repair Market encompasses a range of medical devices including suture anchors, interference screws, grafts, and matrix implants designed to restore anatomical function to damaged soft tissues. Market growth is primarily propelled by the dual forces of an aging demographic susceptible to degenerative tissue changes and a rising participation in high-impact sports among younger cohorts which increases the incidence of acute ruptures. According to the American Academy of Orthopaedic Surgeons, in 2025, the organization released data analyzing over 23,000 rotator cuff repair procedures from their registry, underscoring the substantial clinical volume necessitating these interventions.

One significant challenge that could impede market expansion is the high cost associated with advanced biologic implants and robotic-assisted technologies. These premium solutions often face stringent scrutiny from healthcare payers and insurance providers which can result in limited reimbursement coverage and restrict widespread adoption in cost-sensitive ambulatory surgical centers.

Key Market Drivers

The rising incidence of sports-related injuries serves as a critical determinant of market trajectory, driven by intensified participation in high-impact activities across demographic spectrums. As amateur and professional athletes increasingly engage in strenuous physical regimens, the frequency of acute tendon ruptures, particularly in the lower extremities and shoulder, has surged. This elevation in trauma volume directly necessitates a higher number of surgical interventions, sustaining demand for specialized repair devices and reinforcing the clinical need for robust soft tissue fixation solutions. According to the National Safety Council, November 2025, in the 'Injury Facts' database, 4.4 million people were treated in emergency departments for sports and recreational injuries in 2024, representing a 17% year-over-year increase.

Technological innovations in suture anchors and minimally invasive implants are equally influential, fundamentally altering surgical workflows and patient outcomes. The market is witnessing a decisive shift toward bio-composite materials and robotic-assisted execution, which allow for greater precision and reduced postoperative complications compared to traditional open surgery. Manufacturers are responding by launching sophisticated fixation systems that promote faster healing and integration. According to Zimmer Biomet, November 2025, in the 'Third Quarter 2025 Financial Results', the company reported 5.6% organic revenue growth in its United States business, driven by the accelerated adoption of new product launches and robotic applications. This robust uptake of advanced technologies underscores the sector's expansion. According to Smith+Nephew, in 2025, the Sports Medicine and ENT division achieved an underlying revenue growth of 5.1% during the third quarter, further validating the strong market demand for modern tissue repair modalities.

Download Free Sample Report

Key Market Challenges

The high acquisition costs associated with advanced biologic grafts and robotic systems create a substantial barrier to market growth within the United States. Healthcare payers frequently implement strict evidence requirements before authorizing reimbursement for these premium devices, leading to coverage denials or high out-of-pocket expenses for patients. Consequently, hospitals and ambulatory surgical centers often face financial strain when attempting to integrate these newer technologies into standard practice. This financial pressure forces facilities to prioritize cost containment over the adoption of expensive innovations, limiting the commercial reach of premium products.

This economic constraint is further compounded by declining reimbursement rates for orthopedic procedures. According to the American Academy of Orthopaedic Surgeons, in 2025, the Centers for Medicare & Medicaid Services implemented a 2.83 percent reduction in the physician fee schedule conversion factor. This reduction in reimbursement rates exacerbates the challenges for providers, compelling them to rely on traditional, lower-cost mechanical fixation devices rather than advanced biological options. This trend directly limits the revenue potential for manufacturers of premium tendon repair solutions and slows the overall expansion of the sector.

Key Market Trends

The expansion of outpatient procedures in ambulatory surgery centers is fundamentally reshaping the delivery of tendon repair services in the United States. This migration is driven by the dual benefits of cost containment for payers and enhanced convenience for patients, as advancements in anesthesia and minimally invasive techniques allow for safe same-day discharges. Facilities are increasingly optimizing their operational models to handle higher acuity cases, such as rotator cuff repairs and Achilles tendon reconstructions, which were traditionally confined to inpatient hospital settings. According to Becker's ASC Review, December 2025, in the 'Good news, bad news for ASCs in 2025' article, Surgery Partners reported a 50% increase in total joint volume, reflecting the rapid acceleration of complex orthopedic caseloads shifting into these specialized outpatient environments.

Concurrently, there is a distinct surge in the adoption of bio-inductive scaffolds and collagen matrices designed to augment biological healing rather than relying solely on mechanical fixation. Surgeons are integrating these advanced porous implants to induce the formation of new tendon-like tissue, thereby increasing thickness and reducing the risk of re-tears in compromised soft tissue. This clinical shift focuses on addressing the biological limitations of traditional repairs by providing a regenerative environment that supports long-term structural integrity. According to Conmed, November 2025, in the 'Third Quarter 2025 Financial Results', the company reported that its Orthopedic Surgery segment generated $138.2 million in revenue, a performance significantly bolstered by the expanding clinical adoption of the BioBrace implant among U.S. surgeons.

Segmental Insights

In the United States Tendon Repair Market, the Rotator Cuff Repair segment is identified as the fastest-growing area due to the rising incidence of degenerative shoulder conditions among the aging population. This expansion is further accelerated by an increase in sports-related injuries and the continued adoption of minimally invasive arthroscopic techniques. Moreover, the U.S. Food and Drug Administration (FDA) regularly grants clearances for improved fixation devices, thereby enhancing surgical efficacy and patient recovery. Consequently, these demographic trends and regulatory advancements collectively drive the surging demand for rotator cuff repair procedures across the region.

Regional Insights

The Midwest stands as the leading region in the United States Tendon Repair Market, driven by its exceptional concentration of orthopedic infrastructure and medical expertise. This dominance is anchored by world-class institutions such as the Mayo Clinic and Cleveland Clinic, which are pivotal in the adoption of advanced surgical techniques and procedural innovation. Furthermore, the region benefits from a robust industrial base, hosting the headquarters of major medical device manufacturers in states like Indiana and Michigan. This unique synergy between clinical excellence and device production secures the Midwest's commanding position in the sector.

Recent Developments

• In March 2025, Smith+Nephew reported significant clinical findings regarding its REGENETEN Bioinductive Implant, a collagen-based scaffold used in tendon repair. A randomized controlled trial published in a leading medical journal demonstrated that the implant reduced re-tear rates by 68% in patients with medium to large full-thickness rotator cuff tears compared to the standard of care alone. The study highlighted the device's ability to facilitate the formation of new tendon-like tissue and biologically augment existing structures. These results were intended to drive further adoption of the technology among surgeons treating soft tissue injuries in the sports medicine market.
• In January 2025, Zimmer Biomet entered into a definitive agreement to acquire Paragon 28, a medical device company specializing in the foot and ankle orthopedic segment. The transaction, valued at approximately $1.1 billion, was established to diversify the acquirer's portfolio beyond core orthopedics and into the high-growth area of soft tissue and tendon repair. By integrating the target company's extensive suite of surgical systems and biologics, Zimmer Biomet aimed to create cross-selling opportunities within the ambulatory surgery center space and address unmet patient needs in complex ankle and foot anatomy.
• In July 2024, Anika Therapeutics announced the full commercial release of its Integrity Implant System across the United States. This regenerative hyaluronic acid-based scaffold was developed to augment injured tendons and promote healing in procedures such as rotator cuff repairs. The system, which had previously been in limited release, included fixation components and single-use arthroscopic delivery instruments designed for surgical efficiency. Clinical data and bench-top testing indicated that the implant provided significantly higher tensile strength and tear resistance compared to leading collagen competitors, marking a strategic expansion of the company's regenerative solutions portfolio.
• In January 2024, Paragon 28 expanded its soft tissue portfolio in the United States with the commercial launch of the Grappler Knotless Anchor System and Bridgeline Tape. These new solutions were designed to address complex foot and ankle conditions, complementing the company's existing hardware offerings. The Grappler system featured a sterile kit developed to reduce waste and intraoperative complexity, while the Bridgeline Tape utilized a novel semi-resorbable material intended to transition from rigid stabilization to a natural physiological state during healing. This product introduction aimed to strengthen the company's presence in the rapidly growing soft tissue and tendon repair sector.

Key Market Players

• Arthrex, Inc.
• Smith & Nephew plc
• Stryker Corporation
• Zimmer Biomet Holdings, Inc.
• DePuy Synthes (Johnson & Johnson)
• Orthofix Medical Inc.
• Conmed Corporation
• B. Braun Melsungen AG
• Mitek (Johnson & Johnson)
• Integra LifeSciences Corporation

By Product	By Ventilation Mode/Interphase	By Region
Rotator Cuff Repair Achilles Tendinosis Repair Cruciate Ligament Repair Biceps Tenodesis Others	Implants Suture Anchor Devices Grafts Matrix/Scaffolds (Tendon Repair Tendon Protection Matrix/Scaffolds) Screws Others	Northeast Midwest South West

Report Scope:

In this report, the United States Tendon Repair Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

• United States Tendon Repair Market, By Product:

• Rotator Cuff Repair
• Achilles Tendinosis Repair
• Cruciate Ligament Repair
• Biceps Tenodesis
• Others

• United States Tendon Repair Market, By Ventilation Mode/Interphase:

• Implants
• Suture Anchor Devices
• Grafts
• Matrix/Scaffolds (Tendon Repair
• Tendon Protection Matrix/Scaffolds)
• Screws
• Others

• United States Tendon Repair Market, By Region:

• Northeast
• Midwest
• South
• West